natgillin/translations-raw huggingface dataset:
QUALITATIVE AND QUANTITATIVE COMPOSITION One vial delivers 2 mg of somatropin* (corresponding to 6 IU). 
KAKOVOSTNA IN KOLIČINSKA SESTAVA Ena viala dostavi 2 mg somatropina* (kar ustreza 6 i.e.).
Apply gentle pressure by pushing the plunger up, until all bubbles are removed from the syringe and needle. 
Na bat nežno pritiskajte, dokler ne odstranite vseh mehurčkov iz injekcijske brizge in igle.
Somatropin Biopartners is a powder and solvent for prolonged-release suspension for injection. 
Zdravilo Somatropin Biopartners je prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem.
Somatropin Biopartners 20 mg should be reconstituted with 1.2 mL solvent. 
Zdravilo Somatropin Biopartners 20 mg je treba rekonstituirati z 1,2 ml vehikla.
The 10-mg vial contains an overfill of somatropin powder to allow the withdrawal of up to 10 mg (0.5 mL suspension) of somatropin when reconstituted. 
10-mg viala vsebuje presežek praška somatropina, kar omogoči odvzem do 10 mg (0,5 ml suspenzije) rekonstituiranega somatropina.
- If you have any further questions, ask your doctor, pharmacist or nurse. 
- Če imate dodatna vprašanja, se posvetujte s svojim zdravnikom, farmacevtom ali medicinsko
Powder: sodium hyaluronate, egg phospholipids, sodium dihydrogen phosphate anhydrous, disodium phosphate anhydrous. 
Prašek: natrijev hialuronat, jajčni fosfolipidi, brezvodni natrijev dihidrogenfosfat, brezvodni dinatrijev fosfat.
1 vial of powder and 1 vial of solvent. 
1 viala praška in 1 viala vehikla.
After reconstitution, 1 mL of suspension contains 20 mg (20 mg/mL). 
Po rekonstituciji 1 ml suspenzije vsebuje 20 mg (20 mg/ml)
Pack size of 1 vial of powder and 1 vial of solvent and 4 vials of powder and 4 vials of solvent. 
Velikost pakiranja 1 viala s praškom in 1 viala z vehiklom ter 4 viale s praškom in 4 viale z
For children heavier than 20 kg, Somatropin Biopartners 20 mg powder and solvent for prolonged-release suspension for injection is available. 
Za otroke s telesno maso več kot 20 kg je na voljo zdravilo Somatropin Biopartners 20 mg prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem.
Gastrointestinal disorders Common: vomitting (1.1%), abdominal pain (1.1%) 
Bolezni prebavil pogosti: bruhanje (1,1 %), bolečine v trebuhu (1,1 %)
This medicine is used to treat failure to grow normally (growth deficiency) in children and adolescents aged 2 to 18 years with insufficient secretion of growth hormone. 
To zdravilo se uporablja pri otrocih in mladostnikih, starih od 2 do 8 let, ki zaradi nezadostnega izločanja ratsnega hormona ne rastejo ustrezno (pomanjkanje rastnega hormona).
This is because the doctor will stop the treatment should a tumour occur. 
Če se pojavi tumor, bo zdravnik zdravljenje ustavil.
Somatropin Biopartners is not recommended during pregnancy. 
Zdravila Somatropin Biopartners ne uporabljajte pri nosečnicah.
Reproductive system and breast disorders Common: Nipple pain Uncommon: Gynaecomastia* 
Motnje reprodukcije in dojk pogosti: boleče bradavice občasni:ginekomastija*
Any suspension remaining after the injection should 
Zavrzite suspenzijo, ki bi morebiti ostala po injiciranju.
For children up to 20 kg Somatropin Biopartners 10 mg powder and solvent for prolonged-release suspension for injection is available. 
Za otroke s telesno maso do 20 kg je na voljo zdravilo Somatropin Biopartners 10 mg prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem.
One powder vial delivers 7 mg of somatropin (21 IU). 
Ena viala s praškom dostavi 7 mg somatropina (21 i.e.).
4 vials of powder and 4 vials of solvent. 
4 viale praška in 4 viale vehikla.
To remove any bubbles, gently tap the syringe. 
Da odstranite mehurčke, nežno potrkajte po injekcijski brizgi.
- Somatropin Biopartners 7 mg: One vial of powder delivers 7 mg somatropin, corresponding to 21 IU. 
- Somatropin Biopartners 7 mg: Ena viala s praškom dostavi 7 mg somatropina, kar ustreza 21 i.e..
After preparation, 1 mL of suspension contains 20 mg somatropin (20 mg/mL). 
Po rekonstituciji 1 ml suspenzije vsebuje 20 mg somatropina (20 mg/ml).
No clinical studies have been conducted with Somatropin Biopartners in breast-feeding women. 
Kliničnih študij z zdravilom Somatropin Biopartners niso opravili.
After reconstitution, 0.5 mL of suspension contains 10 mg (20 mg/mL). 
Po rekonstituciji 0,5 ml suspenzije vsebuje 10 mg (20 mg/ml)
One powder vial delivers 20 mg of somatropin (60 IU). 
Ena viala s praškom dostavi 20 mg somatropina (60 i.e.).
There is no relevant use of Somatropin Biopartners 7 mg in the paediatric population in the indication of long-term treatment of growth failure due to insufficient secretion of endogenous growth hormone. 
Zdravilo Somatropin Biopartners 7 mg ni primerno za uporabo pri pediatrični populaciji za indikacijo dolgoročnega zdravljenja zaostanka v rasti zaradi nezadostnega izločanja endogenega rastnega hormona.
Common: Haematuria, increased blood uric acid, increased blood creatinine Reproductive system and breast disorders 
Bolezni sečil pogosti: hematurija, povečana raven sečne kisline v krvi, povečana raven kreatinina v krvi
There is no relevant use of Somatropin Biopartners 4 mg in the paediatric population in the indication of long-term treatment of growth failure due to insufficient secretion of endogenous growth hormone. 
Zdravilo Somatropin Biopartners 4 mg ni primerno za uporabo pri pediatrični populaciji za indikacijo dolgoročnega zdravljenja zaostanka v rasti zaradi nezadostnega izločanja endogenega rastnega hormona.
After reconstitution, 0.7 mL of suspension contains 7 mg (10 mg/mL). 
Po rekonstituciji 0,7 ml suspenzije vsebuje 7 mg (10 mg/ml).
What Somatropin Biopartners contains 
Kaj vsebuje zdravilo Somatropin Biopartners
One powder vial delivers 10 mg of somatropin (30 IU). 
Ena viala s praškom dostavi 10 mg somatropina (30 i.e.).
There is no relevant use of Somatropin Biopartners 2 mg in the paediatric population in the indication of long-term treatment of growth failure due to insufficient secretion of endogenous growth hormone. 
Zdravilo Somatropin Biopartners 2 mg ni primerno za uporabo pri pediatrični populaciji za indikacijo dolgoročnega zdravljenja zaostanka v rasti zaradi nezadostnega izločanja endogenega rastnega hormona.
Excipients 
Protitelesa
One powder vial delivers 2 mg of somatropin (6 IU). 
Ena viala s praškom dostavi 2 mg somatropina (6 i.e.).
- Somatropin Biopartners 2 mg: One vial of powder delivers 2 mg somatropin, corresponding to 6 IU. 
- Somatropin Biopartners 2 mg: Ena viala s praškom dostavi 2 mg somatropina, kar ustreza 6 i.e..
MARKETING AUTHORISATION NUMBER(S) EU/1/13/849/006 1 vial of powder and 1 vial of solvent EU/1/13/849/007 4 vials of powder and 4 vials of solvent 
EU/1/13/849/006 1 viala s praškom in 1 viala z vehiklom EU/1/13/849/007 4 viale s praškom in 4 viale z vehiklom
The syringe should be held upright and gentle pressure applied to the plunger until a small drop of suspension appears at the end of the needle. 
Injekcijsko brizgo držite navpik in z nežnim pritiskanjem na bat iztisnite majhno kapljico na koncu igle.
- Somatropin Biopartners 4 mg: One vial of powder delivers 4 mg somatropin, corresponding to 12 IU. 
- Somatropin Biopartners 4 mg: Ena viala s praškom dostavi 4 mg somatropina, kar ustreza 12 i.e..
After reconstitution, 0.4 mL of suspension contains 4 mg (10 mg/mL). 
Po rekonstituciji 0,4 ml suspenzije vsebuje 4 mg (10 g/ml).
After reconstitution, 0.2 mL of suspension contains 2 mg (10 mg/mL). 
Po rekonstituciji 0,2 ml suspenzije vsebuje 2 mg (10 g/ml).
After preparation, 0.5 mL of suspension contains 10 mg somatropin (20 mg/mL). 
Po rekonstituciji 0,5 ml suspenzije vsebuje 10 mg somatropina (20 mg/ml).
- Somatropin Biopartners 10 mg: One vial of powder delivers 10 mg somatropin, corresponding to 30 IU. 
- Somatropin Biopartners 10 mg: Ena viala s praškom dostavi 10 mg somatropina, kar ustreza 30 i.e..
MARKETING AUTHORISATION NUMBER(S) EU/1/13/849/004 1 vial of powder and 1 vial of solvent EU/1/13/849/005 4 vials of powder and 4 vials of solvent 
EU/1/13/849/004 1 viala s praškom in 1 viala z vehiklom EU/1/13/849/005 4 viale s praškom in 4 viale z vehiklom
Powder and solvent for prolonged-release suspension for injection 1 vial of 10 mg powder 
Vehikel: srednjeverižni trigliceridi prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem 1 viala z 10 mg praška
After preparation, 0.7 mL of suspension contains 7 mg somatropin (10 mg/mL). 
Po rekonstituciji 0,7 ml suspenzije vsebuje 7 mg somatropina (10 mg/ml).
Apply gentle pressure to the plunger to get rid of the bubbles. 
Na bat nežno pritiskajte, da mehurčke iztisnete.
The vial contains an overfill of somatropin powder to allow the withdrawal of up to 4 mg (0.4 mL suspension) of somatropin when reconstituted. 
Viala vsebuje presežek praška somatropina, kar omogoči odvzem do 4 mg (0,4 ml suspezije) rekonstituiranega somatropina.
The vial contains an overfill of somatropin powder to allow the withdrawal of up to 7 mg (0.7 mL suspension) of somatropin when reconstituted. 
Viala vsebuje presežek praška somatropina, kar omogoči odvzem do 7 mg (0,7 ml suspezije) rekonstituiranega somatropina.
The vial contains an overfill of somatropin powder to allow the withdrawal of up to 2 mg (0.2 mL suspension) of somatropin when reconstituted. 
Viala vsebuje presežek praška somatropina, kar omogoči odvzem do 2 mg (0,2 ml suspezije) rekonstituiranega somatropina.
One powder vial delivers 4 mg of somatropin (12 IU). 
Ena viala s praškom dostavi 4 mg somatropina (12 i.e.).
Somatropin Biopartners 4 mg should be reconstituted with 0.6 mL solvent. 
Zdravilo Somatropin Biopartners 4 mg je treba rekonstituirati z 0,6 ml vehikla.
INFORMATION IN BRAILLE Somatropin Biopartners 7 mg 
PODATKI V BRAILLOVI PISAVI Somatropin Biopartners 7 mg
Caution should be exercised when this medicinal product is administered to breast-feeding women. 
Pri dajanju tega zdravila je potrebna previdnost.
The weekly dose of 0.5 mg of somatropin per kilogram of body weight should not be exceeded due to limited experience with higher doses in children. 
Zaradi omejenih izkušenj pri z dajanjem višjih odmerkov otrokom ne presezite tedenskega odmerka 0,5 mg somatropina na kilogram telesne mase.
After reconstitution, 0.2 mL of suspension contains 2 mg somatropin (10 mg/mL). 
Po rekonstituciji 0,2 ml suspenzije vsebuje 2 mg somatropina (10 mg/ml).
After preparation, 0.4 mL of suspension contains 4 mg somatropin (10 mg/mL). 
Po rekonstituciji 0,4 ml suspenzije vsebuje 4 mg somatropina (10 mg/ml).
To remove small air bubbles the syringe should be tapped gently. 
Da odstranite zračne mehurčke, nežno potrkajte po injekcijski brizgi.
- Somatropin Biopartners 20 mg: One vial of powder delivers 20 mg somatropin, corresponding to 60 IU. 
- Somatropin Biopartners 10 mg: Ena viala s praškom dostavi 20 mg somatropina, kar ustreza 60 i.e..
- Somatropin Biopartners 20 mg: 20 mg (60 IU) somatropin as powder in a glass vial closed with a rubber stopper (butyl) and a green flip-off cap (aluminium and plastic) and 1.5 mL solvent (medium chain triglycerides) in glass vial with a rubber stopper (butyl). 
- Somatropin Biopartners 20 mg: 20 mg (60 i.e.) somatropina v obliki praška v stekleni viali, zaprti z gumijastim zamaškom (butil) in zeleno prekrivno zaporko (aluminij in plastika) in 1,5 ml vehikla (srednjeverižni trigliceridi) v stekleni viali z gumijastim zamaškom (butil).
Somatropin Biopartners 2 mg should be reconstituted with 0.4 mL solvent. 
Zdravilo Somatropin Biopartners 2 mg je treba rekonstituirati z 0,4 ml vehikla.
It is recommended to monitor thyroid function following an overdose. 
Po prevelikem odmerjanju se priporoča spremljanje delovanja ščitnice.
INFORMATION IN BRAILLE Somatropin Biopartners 4 mg 
PODATKI V BRAILLOVI PISAVI Somatropin Biopartners 4 mg
Somatropin Biopartners 10 mg should be reconstituted with 0.7 mL solvent. 
Zdravilo Somatropin Biopartners 10 mg je treba rekonstituirati z 0,7 ml vehikla.
Somatropin Biopartners 7 mg should be reconstituted with 0.9 mL solvent. 
Zdravilo Somatropin Biopartners 7 mg je treba rekonstituirati z 0,9 ml vehikla.
Ear and labyrinth disorders Common: Vertigo 
Ušesne bolezni, vključno z motnjami labirinta pogosti: vrtoglavica
- Somatropin Biopartners 2 mg: 2 mg (6 IU) somatropin as powder in a glass vial closed with a rubber stopper (butyl) and a yellow flip-off cap (aluminium and plastic) and 1.5 mL solvent (medium chain triglycerides) in a glass vial with a rubber stopper (butyl). 
- Somatropin Biopartners 2 mg: 2 mg (6 i.e.) somatropina v obliki praška v stekleni viali, zaprti z gumijastim zamaškom (butil) in rumeno prekrivno zaporko (aluminij in plastika) in 1,5 ml vehikla (srednjeverižni trigliceridi) v stekleni viali z gumijastim zamaškom (butil).
- Somatropin Biopartners 10 mg: 10 mg (30 IU) somatropin as powder in a glass vial closed with a rubber stopper (butyl) and a light-green flip-off cap (aluminium and plastic) and 1.5 mL solvent (medium chain triglycerides) in glass vial with a rubber stopper (butyl). 
- Somatropin Biopartners 10 mg: 10 mg (30 i.e.) somatropina v obliki praška v stekleni viali, zaprti z gumijastim zamaškom (butil) in svetlozeleno prekrivno zaporko (aluminij in plastika) in 1,5 ml vehikla (srednjeverižni trigliceridi) v stekleni viali z gumijastim zamaškom (butil).
Hold the fold between the thumb and the forefinger during the entire injection. 
Gubo ves čas injiciranja držite s palcem in kazalcem.
INFORMATION IN BRAILLE Somatropin Biopartners 20 mg 
ZUNANJA OVOJNINA SOMATROPIN BIOPARTNERS 20 MG
- Somatropin Biopartners 7 mg: 7 mg (21 IU) somatropin as powder in a glass vial closed with a rubber stopper (butyl) and a light-blue flip-off cap (aluminium and plastic) and 1.5 mL solvent (medium chain triglycerides) in glass vial with a rubber stopper (butyl). 
Somatropin Biopartners 7 mg: 7 mg (21 i.e.) somatropina v obliki praška v stekleni viali, zaprti z gumijastim zamaškom (butil) in svetlomodro prekrivno zaporko (aluminij in plastika) in 1,5 ml vehikla (srednjeverižni trigliceridi) v stekleni viali z gumijastim zamaškom (butil).
Pack size: 4 vials of powder and 4 vials of solvent. 
Velikost pakiranja: 4 viale s praškom in 4 viale z vehiklom.
- Somatropin Biopartners 4 mg: 4 mg (12 IU) somatropin as powder in a glass vial closed with a rubber stopper (butyl) and a pink flip-off cap (aluminium and plastic) and 1.5 mL solvent (medium chain triglycerides) in glass vial with a rubber stopper (butyl). 
- Somatropin Biopartners 4 mg: 4 mg (12 i.e.) somatropina v obliki praška v stekleni viali, zaprti z gumijastim zamaškom (butil) in rožnato prekrivno zaporko (aluminij in plastika) in 1,5 ml vehikla (srednjeverižni trigliceridi) v stekleni viali z gumijastim zamaškom (butil) Velikost pakiranja 4 viale praška in 4 viale vehikla.
Powder and solvent for prolonged-release suspension for injection 4 vials of 7 mg powder 
Vehikel: srednjeverižni trigliceridi prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem 4 viale s 7 mg praška
Each vial of powder delivers 20 mg somatropin; each vial of solvent contains 1.5 mL liquid. 
Ena viala praška dostavi 20 mg somatropina; ena viala vehikla vsebuje 1,5 ml tekočine.
NAME OF THE MEDICINAL PRODUCT Somatropin Biopartners 7 mg powder and solvent for prolonged-release suspension for injection 
IME ZDRAVILA Somatropin Biopartners 7 mg prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem
The vial should be turned upside down, with the syringe in and the tip of the needle should be placed in the solvent. 
Vialo nato obrnite navzdol z vstavljeno injekcijsko brizgo, pri tem naj bo konica igle v vehiklu.
Sodium dihydrogen phosphate anhydrous Disodium phosphate anhydrous. 
Prašek: natrijev hialuronat jajčni fosfolipidi brezvodni natrijev dihidrogenfosfat brezvodni dinatrijev fosfat
Renal/hepatic impairment 
Okvarjeno delovanje ledvic/jeter
NAME OF THE MEDICINAL PRODUCT Somatropin Biopartners 4 mg powder and solvent for prolonged-release suspension for injection 
IME ZDRAVILA Somatropin Biopartners 4 mg prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem
Each vial of powder delivers 7 mg somatropin; each vial of solvent contains 1.5 mL liquid. 
Ena viala praška dostavi 7 mg somatropina; ena viala vehikla vsebuje 1,5 ml tekočine.
Powder and solvent for prolonged-release suspension for injection. 
prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem Bel do belkast prašek.
MARKETING AUTHORISATION NUMBER(S) EU/1/13/849/002 4 vials of powder and 4 vials of solvent 
ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/13/849/002 4 viale s praškom in 4 viale z vehiklom 13.
NAME OF THE MEDICINAL PRODUCT Somatropin Biopartners 2 mg powder and solvent for prolonged-release suspension for injection 
IME ZDRAVILA Somatropin Biopartners 2 mg prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem
MARKETING AUTHORISATION NUMBER(S) EU/1/13/849/003 4 vials of powder and 4 vials of solvent 
ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/13/849/003 4 viale s praškom in 4 viale z vehiklom 13.
Powder and solvent for prolonged-release suspension for injection 4 vials of 2 mg powder 
Vehikel: srednjeverižni trigliceridi prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem 4 viale z 2 mg praška
Powder and solvent for prolonged-release suspension for injection 4 vials of 4 mg powder 
Vehikel: srednjeverižni trigliceridi prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem 4 viale z 4 mg praška
Egg phospholipids 
PODATKI NA ZUNANJI OVOJNINI
Somatropin Biopartners 20 mg powder and solvent for prolonged-release suspension for injection 
Somatropin Biopartners 20 mg prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem
Somatropin Biopartners 10 mg powder and solvent for prolonged-release suspension for injection 
Somatropin Biopartners 10 mg prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem
Somatropin Biopartners 4 mg powder for prolonged-release suspension for injection somatropin 
Somatropin Biopartners 4 mg prašek za suspenzijo za injiciranje s podaljšanim sproščanjem somatropin s.c. za odrasle
Treatment should be discontinued if there is evidence of tumour 
Če obstajajo znaki rasti tumorja, je treba zdravljenje prekiniti.
Testing for antibodies to somatropin may be considered in patients with otherwise unexplained lack of growth response. 
Pri bolnikih, pri katerih pomanjkanja rastnega odziva ni mogoče drugače razložiti, se lahko opravi test na protitelesa na somatropin.
Somatropin Biopartners 2 mg powder for prolonged-release suspension for injection somatropin 
Somatropin Biopartners 2 mg prašek za suspenzijo za injiciranje s podaljšanim sproščanjem somatropin s.c. za odrasle
Each vial of powder delivers 2 mg somatropin; each vial of solvent contains 1.5 mL liquid. 
Ena viala praška dostavi 2 mg somatropina; ena viala vehikla vsebuje 1,5 ml tekočine.
Each vial of powder delivers 10 mg somatropin; each vial of solvent contains 1.5 mL liquid. 
Ena viala praška dostavi 10 mg somatropina; ena viala vehikla vsebuje 1,5 ml tekočine.
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS VIAL OF SOLVENT 
PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
Each vial of powder delivers 4 mg somatropin; each vial of solvent contains 1.5 mL liquid. 
Ena viala praška dostavi 4 mg somatropina; ena viala vehikla vsebuje 1,5 ml tekočine.
Powder: Vial (type I glass) closed with a rubber stopper (butyl) and a pink flip-off cap (aluminium and plastic). 
Prašek: Viala (steklo tipa I), zaprta z gumijastim zamaškom (butil) in rožnato prekrivno zaporko (aluminij in plastika).
INFORMATION IN BRAILLE Somatropin Biopartners 2 mg 
ZUNANJA OVOJNINA SOMATROPIN BIOPARTNERS 2 MG
Talk to your doctor before using Somatropin Biopartners if you: - have a hereditary disease called Prader-Willi syndrome: You should not be treated with this medicine unless you also have a lack of growth hormone; - have had a tumour: Your doctor will examine you frequently to ensure that the tumour has not come back; - have symptoms like severe and recurrent headache, visual changes, nausea and/or vomiting which may be due to increased pressure in the skull during growth hormone treatment; - suffer from an organic growth hormone deficiency (lack of growth hormone due to damage to the pituitary gland or the part of the brain called the hypothalamus) or decreased secretion of 
Pred začetkom uporabe zdravila Somatropin Biopartners se posvetujte s svojim zdravnikom, če: - imate dedno bolezen, imenovano Prader-Willijev sindrom: s tem zdravilom se ne smete zdraviti, če nimate hkrati tudi pomanjkanja rastnega hormona.
Somatropin Biopartners 7 mg powder for prolonged-release suspension for injection somatropin 
Somatropin Biopartners 7 mg prašek za suspenzijo za injiciranje s podaljšanim sproščanjem somatropin s.c. za odrasle
INFORMATION IN BRAILLE Somatropin Biopartners 10 mg 
ZUNANJA OVOJNINA SOMATROPIN BIOPARTNERS 10 MG
Somatropin Biopartners 7 mg powder and solvent for prolonged-release suspension for injection Somatropin 
Somatropin Biopartners 7 mg prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem somatropin za odrasle
Powder: Vial (type I glass) closed with a rubber stopper (butyl) and a yellow flip-off cap (aluminium and plastic). 
Prašek: Viala (steklo tipa I), zaprta z gumijastim zamaškom (butil) in rumeno prekrivno zaporko (aluminij in plastika).
Somatropin Biopartners 2 mg powder and solvent for prolonged-release suspension for injection somatropin 
Somatropin Biopartners 2 mg prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem somatropin za odrasle
Powder: Vial (type I glass) closed with a rubber stopper (butyl) and a green flip-off cap (aluminium and plastic). 
Prašek: Viala (steklo tipa I), zaprta z gumijastim zamaškom (butil) in zeleno prekrivno zaporko (aluminij in plastika).
Somatropin Biopartners 4 mg powder and solvent prolonged-release for suspension for injection somatropin 
Somatropin Biopartners 4 mg prašek in vehikel za suspenzijo za injiciranje s podaljšanim sproščanjem somatropin za odrasle
Solvent: Vial (Type I glass) closed with a rubber stopper (butyl) and a flip-off cap (aluminium and plastic). 
Vehikel: Viala (steklo tipa I), zaprta z gumijastim zamaškom (butil) in prekrivno zaporko (aluminij in plastika).
Powder: Vial (type I glass) closed with a rubber stopper (butyl) and a light-green flip-off cap (aluminium and plastic). 
Prašek: Viala (steklo tipa I), zaprta z gumijastim zamaškom (butil) in svetlozeleno prekrivno zaporko (aluminij in plastika).
Gently pinch the skin that has been cleaned, to make a fold. 
Očiščeno kožo nežno stisnite v gubo.
Pack size of 4 vials of powder and 4 vials of solvent. 
Velikost pakiranja 4 viale praška in 4 viale vehikla.
Remove the needle guard. 
- Navodilo shranite.
Respiratory, thoracic and mediastinal disorders Common: Epistaxis 
Bolezni dihal, prsnega koša in mediastinalnega prostora pogosti: krvavitev iz nosu
6.3 Shelf life 
6.3 Seznam pomožnih snovi
Further information on Doptelet can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/doptelet. 
Nadaljnje informacije o zdravilu Doptelet so na voljo na spletni strani agencije: ema.europa.eu/medicines/human/EPAR/doptelet.
It is available as 20-mg tablets. 
Na voljo je v obliki 20-miligramskih tablet.
Treatment with Doptelet should start at least 10 days before the procedure. 
Zdravljenje z zdravilom Doptelet se mora začeti vsaj deset dni pred postopkom.
The European Medicines Agency decided that Doptelet's benefits are greater than its risks and it can be authorised for use in the EU. 
Evropska agencija za zdravila je zaključila, da so koristi zdravila Doptelet večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
Other information about Doptelet 
Druge informacije o zdravilu Doptelet
What measures are being taken to ensure the safe and effective use of Doptelet? 
Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Doptelet?
As for all medicines, data on the use of Doptelet are continuously monitored. 
Tako kot za vsako zdravilo se tudi podatki o uporabi zdravila Doptelet stalno spremljajo.
What is Doptelet and what is it used for? 
Kaj je zdravilo Doptelet in za kaj se uporablja?